potential

Hotel giant Marriott International (NASDAQ:MAR) has recently increased its annual adjusted profit forecast following a mixed performance in the first quarter. Despite weakening trends in North America, Marriott is relying on the surge in international travel demand to drive its full-year profit. The company anticipates a significant boost in revenue per available room (RevPAR) from
0 Comments
The impact of higher-for-longer U.S. interest rates was felt across Asian stock markets on Wednesday, with Japanese and Australian stocks leading the losses. This negative sentiment was fueled by fears of prolonged U.S. interest rate hikes, as investors awaited the conclusion of a Federal Reserve meeting later in the day. Japanese Stock Market Performance Japan’s
0 Comments
Australia’s major banks are anticipated to report weaker first-half profits as operating costs remain high and competition for mortgage and deposit sales intensifies. This has led to a reduction in margins, putting a strain on overall profitability. Although historically, rising interest rates have been beneficial for the Big Four banks, the current scenario has forced
0 Comments
Amazon recently reported its first-quarter earnings, surpassing expectations with both its earnings per share and revenue figures. The company’s revenue of $143.3 billion exceeded the forecasted $142.5 billion, while its earnings per share of 98 cents outperformed the expected 83 cents. The stock market reacted positively to the news, with Amazon’s stock price rising during
0 Comments
In recent years, the landscape of movie distribution has undergone significant changes, especially with the rise of eventized movies such as concert films. With the onset of the Covid-19 pandemic, studios began to embrace the theatrical day-and-date model as cinemas closed. However, the realization that theatrical releases bring in more profits and downstream revenues became
0 Comments
The recent ruling by U.S. District Judge Zahid Quraishi in Trenton, New Jersey, to uphold the law requiring drug manufacturers like Bristol Myers Squibb and Johnson & Johnson to negotiate prices of their blood clot prevention drugs with the U.S government’s Medicare program has sparked controversy in the pharmaceutical industry. Despite the drug companies’ arguments
0 Comments
After a prolonged period of dormancy, the Initial Public Offering (IPO) market seems to be making a comeback. Colin Stewart, Morgan Stanley’s global head of technology equity capital markets, expressed optimism about the resurgence of tech companies going public. Stewart predicts that 10 to 15 more tech firms could launch IPOs by the end of
0 Comments